HomeCompareVRAY vs DGRO

VRAY vs DGRO: Dividend Comparison 2026

VRAY yields 8000.00% · DGRO yields 2.11%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VRAY wins by $6139401296821770.00M in total portfolio value
10 years
VRAY
VRAY
● Live price
8000.00%
Share price
$0.03
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$6139401296821770.00M
Annual income
$5,992,060,180,362,265,000,000.00
Full VRAY calculator →
DGRO
iShares Core Dividend Growth ETF
● Live price
2.11%
Share price
$69.63
Annual div
$1.47
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$31.6K
Annual income
$237.48
Full DGRO calculator →

Portfolio growth — VRAY vs DGRO

📍 VRAY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVRAYDGRO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VRAY + DGRO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
VRAY pays
DGRO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VRAY
Annual income on $10K today (after 15% tax)
$680,000.00/yr
After 10yr DRIP, annual income (after tax)
$5,093,251,153,307,925,000,000.00/yr
DGRO
Annual income on $10K today (after 15% tax)
$179.56/yr
After 10yr DRIP, annual income (after tax)
$201.86/yr
At 15% tax rate, VRAY beats the other by $5,093,251,153,307,925,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VRAY + DGRO for your $10,000?

VRAY: 50%DGRO: 50%
100% DGRO50/50100% VRAY
Portfolio after 10yr
$3069700648410885.00M
Annual income
$2,996,030,090,181,132,400,000.00/yr
Blended yield
97.60%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on VRAY right now

VRAY
Analyst Ratings
3
Buy
8
Hold
Consensus: Hold
Price Target
$6.25
+24900.0% upside vs current
Range: $4.00 — $8.00
Altman Z
-6.1
Piotroski
3/9
DGRO
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VRAY buys
1
DGRO buys
9
PoliticianChamberTickerTypeAmountDate
Scott Mr Franklin🏢 House$DGRO▼ Sell$15,001 - $50,0002024-08-06
Kevin Hern🏢 House$DGRO▲ Buy$1,001 - $15,0002022-09-30
Kevin Hern🏢 House$DGRO▲ Buy$1,001 - $15,0002021-09-30
Kevin Hern🏢 House$DGRO▲ Buy$250,001 - $500,0002021-07-01
K. Michael Conaway🏢 House$DGRO▲ Buy$50,001 - $100,0002020-12-17
K. Michael Conaway🏢 House$DGRO▲ Buy$15,001 - $50,0002020-11-30
K. Michael Conaway🏢 House$DGRO▲ Buy$50,001 - $100,0002020-08-10
K. Michael Conaway🏢 House$DGRO▲ Buy$15,001 - $50,0002020-04-22
K. Michael Conaway🏢 House$DGRO▲ Buy$1,001 - $15,0002020-04-06
K. Michael Conaway🏢 House$DGRO▲ Buy$15,001 - $50,0002020-04-06
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVRAYDGRO
Forward yield8000.00%2.11%
Annual dividend / share$2.00$1.47
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$6139401296821770.00M$31.6K
Annual income after 10y$5,992,060,180,362,265,000,000.00$237.48
Total dividends collected$6129555735022888.00M$2.3K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: VRAY vs DGRO ($10,000, DRIP)

YearVRAY PortfolioVRAY Income/yrDGRO PortfolioDGRO Income/yrGap
1← crossover$810,700$800,000.00$11,291$211.24+$799.4KVRAY
2$61,480,533$60,613,084.11$12,726$215.27+$61.47MVRAY
3$4,361,742,463$4,295,958,292.40$14,319$218.97+$4361.73MVRAY
4$289,505,553,392$284,838,488,956.41$16,088$222.38+$289505.54MVRAY
5$17,978,762,985,621$17,668,992,043,491.98$18,051$225.49+$17978762.97MVRAY
6$1,044,726,039,031,441$1,025,488,762,636,826.10$20,229$228.34+$1044726039.01MVRAY
7$56,809,462,631,941,760$55,691,605,770,178,120.00$22,645$230.95+$56809462631.92MVRAY
8$2,891,032,380,267,701,000$2,830,246,255,251,523,600.00$25,324$233.33+$2891032380267.68MVRAY
9$137,701,977,999,537,290,000$134,608,573,352,650,870,000.00$28,294$235.50+$137701977999537.27MVRAY
10$6,139,401,296,821,770,000,000$5,992,060,180,362,265,000,000.00$31,587$237.48+$6139401296821770.00MVRAY

VRAY vs DGRO: Complete Analysis 2026

VRAYStock

ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, France, Taiwan, the United Kingdom, and internationally. The company provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin toxicity, and other concerns. The company serves university research and teaching hospitals, community hospitals, private practices, government institutions, and freestanding cancer centers. ViewRay, Inc. markets its MRIdian through a direct sales force and distribution network. The company was founded in 2004 and is headquartered in Oakwood, Ohio.

Full VRAY Calculator →

DGROETF

The iShares Core Dividend Growth ETF seeks to track the investment results of an index composed of U.S. equities with a history of consistently growing dividends.

Full DGRO Calculator →
📬

Get this VRAY vs DGRO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VRAY vs SCHDVRAY vs JEPIVRAY vs OVRAY vs KOVRAY vs MAINVRAY vs VIGVRAY vs NOBLVRAY vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.